Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
Just nowPlacement
Just nowQ3 FY26 Activities Report and Appendix 4C
Just nowFY26 Q1 Quarterly Activities Report and Appendix 4C
Verrica Pharmaceuticals Inc logo

Verrica Pharmaceuticals Inc

About

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 9 2026
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
Apr 6 2026
Verrica Pharmaceuticals to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 11 2026
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 5 2026
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
Feb 23 2026
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

Financials

Revenue
$35.58 M
Market Cap
$102.73 M
EPS
-1.68

Community Chat

Ask AI

6ix6ix